Pioglitazone Special Drug Use Surveillance "Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus"
Status:
Completed
Trial end date:
2013-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this survey is to determine the onset of new cerebral and cardiovascular
events and changes in metabolic syndrome parameters in patients with type 2 diabetes mellitus
on long-term pioglitazone (Actos Tablets) treatment.